Alternative Management When Insulin 70/30 Fails

Introduction to Alternative Management

The American Diabetes Association recommends switching to a basal-bolus regimen using basal insulin, such as insulin glargine, combined with rapid-acting insulin before meals, or alternatively using basal insulin alone with oral agents, when insulin 70/30 is ineffective or inappropriate 1, 2

Premixed insulin 70/30 carries an unacceptably high risk of iatrogenic hypoglycemia in hospital settings and is explicitly not recommended for inpatient use, according to the American College of Clinical Endocrinologists 1
The fixed ratio of 70/30 lacks flexibility for patients with irregular meal timing, variable carbohydrate intake, or those requiring individualized basal versus prandial coverage, as stated by the European Association for the Study of Diabetes 3

The most effective alternative is a basal-bolus approach using insulin glargine as the basal component combined with rapid-acting insulin analogs before meals, as recommended by the American Association of Clinical Endocrinologists 1, 2

Calculate total daily insulin dose: for insulin-naive patients or those on low doses, start with 0.3-0.5 U/kg per day, according to the International Diabetes Federation 1
Distribute the total daily insulin dose: allocate 50% to basal insulin and 50% to rapid-acting insulin divided before three meals, as suggested by the American Diabetes Association 1, 2
For patients previously on higher insulin doses, reduce total daily insulin dose by 20% when transitioning to prevent hypoglycemia, especially if oral intake is poor, as recommended by the European Association for the Study of Diabetes 1

Never mix insulin glargine with any other insulin in the same syringe, as stated by the American Association of Clinical Endocrinologists 4
Do not convert from premixed insulin to glargine on a 1:1 basis, recalculate total daily insulin dose and redistribute appropriately between basal and prandial components, according to the International Diabetes Federation 3, 5
Discontinue sulfonylureas and DPP-4 inhibitors when intensifying to multiple-dose insulin regimens to reduce hypoglycemia risk, but continue metformin, as recommended by the American Diabetes Association 3
Avoid administering glargine at the same time as any prandial insulin to prevent insulin stacking, as suggested by the European Association for the Study of Diabetes 4
When adding prandial insulin to glargine, reduce the basal dose if making significant additions to evening prandial insulin to minimize overnight hypoglycemia risk, according to the American Association of Clinical Endocrinologists 2

If not already using a GLP-1 receptor agonist, strongly consider adding this to basal insulin before advancing to prandial insulin to address postprandial hyperglycemia while minimizing hypoglycemia and weight gain risks associated with intensified insulin therapy, as recommended by the American Diabetes Association 2